Skip to main content

News & Articles

UTHealth Houston Research

October 20, 2023
Written By: Darla Brown, McGovern Medical School | Updated: October 20, 2023
Just as a song can remind us of the junior high dance or prom, sounds also have the ability to return traumatic memories. Pinpointing the location of these traumatic memories is the work behind a clinical trial, “Neuromodulation of the fear extinction circuit using temporally and anatomically specific TMS in humans,” led by Mohammed Milad, PhD, professor in the Louis A. Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston.
October 19, 2023
Written By: Jeannette Sanchez | Updated: October 19, 2023
The Texas Therapeutics Institute at UTHealth Houston, led by Zhiqiang An, PhD, is expanding into the Texas Medical Center’s newly completed TMC3 Collaborative Building. The institute, part of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases with McGovern Medical School at UTHealth Houston, focuses on antibody drug resistance mechanisms, biomarkers for therapeutic antibodies, and antibody drug discovery targeting human diseases.
September 28, 2023
Written By: Jeannette Sanchez | Updated: September 28, 2023
A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease.
September 14, 2023
Written By: Deborah Mann Lake | Updated: September 14, 2023
R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.
September 12, 2023
Written By: Caitie Barkley | Updated: September 12, 2023
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.